Trial
NCT01315873
Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
Cephalon
Condition
Multiple Myeloma
Intervention
Bendamustine
Why stopped
PI left the institution before all data analysis was completed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-07